NULISA (A NOVEL PROTEOMIC LIQUID BIOPSY PLATFORM WITH ATTOMOLAR SENSITIVITY AND HIGH MULTIPLEXING) TESTING SERVICES TO IDENTIFY BIOMARKERS THAT PROVIDE INFORMATION ABOUT THE UNDERLYING MOLECULAR CHANGES ASSOCIATED WITH AD/ADRD.

PURCHASE ORDER won by BANNER HEALTH · work in ROCKVILLE, MD
$2,332,200
RecipientBANNER HEALTH UEI SB35ENJFKK14
Award ID75N98026P00871
Award amount$2,332,200
Award typePURCHASE ORDER
Awarding agencyDepartment of Health and Human Services — National Institutes of Health
NAICS541380 — TESTING LABORATORIES AND SERVICES
PSCQ301
Set-asideUnrestricted
Start dateAug 1, 2026
End dateJul 31, 2027
Place of performanceROCKVILLE, MD
Record updatedJul 7, 2026

View the official award record

More awards won by BANNER HEALTH

BANNER GRADUATE MEDICAL EDUCATION
Department of Veterans Affairs · $252,479 · Jul 1, 2020

Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.

Search open bids